Anzeige
Meldung des Tages: Drohnenangriffe schockieren die Welt – dieser Tech-Player will die Verteidigung neu definieren

SMI

Index
WKN:  969000 ISIN:  CH0009980894
13.269,64
-2,24%
-304,025
05.03.26
Depot/Watchlist
Weiter abwärts? Short handeln - Jetzt mit Hebel 8,53: VH2UV0
Werbung

Unternehmensmeldungen

05.03.26 - EQS
Holcim recognized as Global Top Employer for 2026
Holcim Group Services Ltd / Key word(s): Miscellaneous Holcim recognized as Global Top Employer for 2026 05.03.2026 / 07:00 CET/CEST
03.03.26 - EQS
Amrize Launches EVERtect™ High-Performance Concrete Range at CONEXPO-CON/AGG 2026
Amrize Ltd / Key word(s): Product Launch Amrize Launches EVERtect™ High-​Performance Concrete Range at CONEXPO-​CON/AGG 2026 03.03.2026 / 17:00 CET/CEST
03.03.26 - EQS
EQS-News: Logitech G Studie: E-Sport tritt in ein goldenes Zeitalter ein
EQS-News: Logitech G / Schlagwort(e): Sonstiges Logitech G Studie: E-Sport tritt in ein goldenes Zeitalter ein 03.03.2026 / 10:55 CET/CEST Für den Inhalt der Mitteilung ist der ...
27.02.26 - GlobeNewswire
Novartis successfully completes acquisition of Avidity Biosciences, strengthening late-stage neuroscience pipeline and advancing xRNA strategy
Adds Avidity’s differentiated muscle-​directed Antibody Oligonucleotide Conjugates (AOC) platform and three late-​stage programs to industry-​leading neuromuscular pipeline ...
27.02.26 - GlobeNewswire
Novartis receives positive CHMP opinion for remibrutinib in chronic spontaneous urticaria (CSU)
Remibrutinib, a highly selective oral BTKi, has potential to be first targeted therapy approved for CSU in Europe Improvements with remibrutinib observed as early as Week 1 in ...
27.02.26 - EQS
Partners Group to sell atNorth for an EV of USD 4 billion
Partners Group / Key word(s): Mergers & Acquisitions Partners Group to sell atNorth for an EV of USD 4 billion 27.02.2026 / 09:00 CET/CEST
27.02.26 - Businesswire
Changes to the UBS Board of Directors
Regulatory News:
25.02.26 - GlobeNewswire
Novartis to build new radioligand therapy site in Denton, Texas, delivering more next‑generation treatments to patients
Facility expected to be operational in 2028 in Dallas-​Fort Worth area, expanding largest RLT manufacturing network in US Site to serve patients in Southern US and add network ...
24.02.26 - Businesswire
Alcon Delivers Strong Fourth-Quarter 2025 Topline Growth as New Product Launches Accelerate Sales
Regulatory News:
24.02.26 - GlobeNewswire
New real‑world data reinforce earlier use of Pluvicto™ before chemotherapy in metastatic castration-resistant prostate cancer
In the real-​world, Pluvicto™ showed 13.5 months median PFS in chemo-naïve patients with PSMA-​positive mCRPC Real ‑ world evidence showed Pluvicto achieved longer PFS when ...
23.02.26 - GlobeNewswire
Novartis presents Rhapsido® (remibrutinib) data at AAAAI, showing potential beyond chronic spontaneous urticaria (CSU)
Analyses from REMIX-1 & -2 studies on CSU disease control and early symptom relief will be presented Phase II data evaluating safety and efficacy results of remibrutinib for ...
23.02.26 - EQS
Partners Group announces planned office in Kuwait, expanding its presence in the GCC
Partners Group / Key word(s): Miscellaneous Partners Group announces planned office in Kuwait, expanding its presence in the GCC 23.02.2026 / 07:00 CET/CEST
20.02.26 - EQS
Partners Group addresses share price falls in listed private markets sector
Partners Group / Key word(s): Statement Partners Group addresses share price falls in listed private markets sector 20.02.2026 / 13:35 CET/CEST
20.02.26 - EQS
Swiss Re Corporate Solutions übernimmt Global Trade Credit and Surety Geschäft von QBE
Swiss Re Ltd / Schlagwort(e): Ankauf Swiss Re Corporate Solutions übernimmt Global Trade Credit and Surety Geschäft von QBE 20.02.2026 / 00:30 CET/CEST
19.02.26 - EQS
Einladung zur Generalversammlung von ABB am 19. März 2026
ABB Ltd / Schlagwort(e): Generalversammlung Einladung zur Generalversammlung von ABB am 19. März 2026 19.02.2026 / 07:00 CET/CEST
18.02.26 - EQS
Amrize Closes Acquisition of PB Materials; Aggregates Leader in High-Growth West Texas
Amrize Ltd / Key word(s): Acquisition Amrize Closes Acquisition of PB Materials; Aggregates Leader in High-​Growth West Texas 18.02.2026 / 22:20 CET/CEST
18.02.26 - GlobeNewswire
Novartis remibrutinib first therapy to achieve Phase III primary endpoint in chronic inducible urticaria (CIndU)
Statistically significant and clinically meaningful results seen in RemIND trial with complete responses achieved in 3 CIndU types 1 Remibrutinib, a highly selective oral BTK ...
13.02.26 - EQS
Changes to the Composition of the Lonza Board
Lonza Group AG / Key word(s): Personnel Changes to the Composition of the Lonza Board 13.02.2026 / 09:00 CET/CEST
13.02.26 - GlobeNewswire
Novartis Vanrafia® Phase III data support slowing of kidney function decline in patients with IgA nephropathy
In ALIGN study, Vanrafia (atrasentan) showed positive difference in eGFR change from baseline vs. placebo at Week 136, 4 weeks after study treatment ended 1 Results favored ...
12.02.26 - Businesswire
Amrize Board of Directors Changes
Regulatory News:

Newssuche

Videos

newspaper
04.03.26 +5,94%
ROHÖL mit Ziel MINUS 40$?!?
Fundierte Strategien für den Handel der wichtigen News in einem Seminarpaket, plus transparenter ... Mehr »